Two Lyme disease vaccines were in development in 2026

Nonwhite Lyme patients tend to be diagnosed later and have more severe disease

Peer-reviewed research published in 2025 from Pfizer—a pharmaceutical company working on a candidate vaccine for Lyme disease—examined Lyme data from more than 150,000 Medicare and Medicaid beneficiaries and found that Black patients, as compared to white beneficiaries, were more likely to have disease that had spread further throughout the body at the time of care. The difference, the scientists wrote, may be partly due to difficulties recognizing the characteristic rash on darker-colored skin.

More than 1 in 7 people worldwide have had Lyme disease

Research published in 2022 suggests that 14.5% of the world's population has contracted Lyme disease. Researchers arrived at that estimate by analyzing the presence of Lyme disease antibodies (indicating prior infection) across 89 studies conducted between January 1984 and December 2021. The works collectively included blood samples from more than 150,000 people. (Some user may encounter a paywall.)

See the total number of Lyme cases per state in 2023

New York, Pennsylvania, and Massachusetts had the highest total number of Lyme disease cases in 2023. New York had more than 22,000 cases that year. Maine had one of the highest Lyme incidence rates of disease that year—213 per 100,000 people—but only 2,942 cases overall.

Lyme disease-causing bacteria predate any suspected biological weapons testing

Borrelia bacteria existed long before any US biological weapons program—or human presence in North America. One study comparing genomes of the bacteria behind Lyme disease collected samples of the bacteria over three decades and calculated that the bacterium has been in North America longer than humans, at least 60,000 years. Other work found related bacteria preserved in amber from millions of years ago.

See the incidence of Lyme disease across all 50 states in 2023

The US states with the highest rate of Lyme disease—meaning cases per 100,000 people—were Rhode Island, Vermont, and Maine, in 2023. Rhode Island had 260 cases per 100,000 people, based on cases reported to the US Centers for Disease Control and Prevention. (Some users may encounter a paywall.)

Post-treatment Lyme disease syndrome may be caused by bacterial remnants in the liver

PTLDS, which refers to lingering symptoms of Lyme after antibiotic treatment, is an area of active research. Rodent research published in 2025 suggests that these ongoing symptoms may potentially be due to the body's inflammatory response to lingering cellular components from the bacteria that cause Lyme, Borrelia burgdorferi. In rodents, components of the bacteria's cellular wall may remain in the liver after the bacteria were eliminated with antibiotics.

Lyme disease was first identified in Lyme, Connecticut in 1975

A cluster of 51 children and adults in the town all began experiencing uncommon arthritic symptoms and the cases were reported to the state health department. A quarter of the cases were preceded by a skin lesion. The patients tended to live near the woods.

Horses have four licensed West Nile vaccines—but humans have none

A major hurdle for West Nile vaccine development is the lack of a market for it since so many people are symptomatic for the infections. Still, a growing number of infections, including a 40% spike in 2025, may change that calculation.

Lyme disease may cost about $1B annually in the US

The economic burden of the disease in this estimate includes direct medical costs and societal costs, including productivity losses. It does not include suspected, undiagnosed, or nonacute cases, which would push that figure upward.

An Ebola vaccine was developed during the 2018 west African Ebola outbreak, but the 2026 Ebola outbreak is with a different species of the virus, not the one that the vaccine is approved to treat.

Lyme disease is the most common vector-borne illness in the US

In the US, ticks account for 90% of all disease transmission from bites, including mosquitoes. And Lyme disease is the most common vector-borne disease in the US overall, with estimates suggesting there are about 475,000 Lyme cases annually across the nation.

Read a study about racial differences in Lyme disease diagnosis

The research published in September 2025 examined differences in Lyme disease diagnosis among Medicaid and Medicare beneficiaries using data from 2016 to 2021. It notes that though US Lyme disease surveillance data indicates more than 90% of diagnosed Lyme cases are among white people, people of color—particularly those who identify as Black or African American—have higher rates of more severe disease of Lyme, with symptoms including arthritis and neurologic impacts.

Genetic engineering mice is one idea to reduce Lyme disease transmission

Wild white-footed mice are the main carriers of Lyme. A research team is hoping to genetically engineer mice, using CRISPR, to make the animals immune to Lyme. They're proposing a field trial where they would insert a gene with an antibody to Lyme infection to break the disease transmission cycle on a private island and then try it in Nantucket if that goes well. Simply killing the mice isn't an option because it would upend food webs. Unlike traditional vaccines, this "heritable immunization" would pass from one generation of mice to the next.

The flu vaccine has evolved alongside discoveries of new virus strains

After influenza B was identified in 1940, researchers created a two-strain vaccine by 1942. The WHO later built a global surveillance system to track mutations, enabling vaccines to be updated annually to target the strains most likely to circulate.

Lyme disease is caused by bacteria transmitted through the bite of infected ticks

It's an infectious disease caused by Borrelia burgdorferi bacteria. It's spread through the bite of two species of infected ticks, the Western blacklegged ticks on the West Coast, and Blacklegged ticks found throughout the eastern US. The ticks can transmit the disease at both the nymph and adult stage. It's not known to be transmitted from one person to another via kissing or sex.

The 2026 Ebola outbreak in the DRC is spurring new Ebola vaccine development for the Bundibugyo species.

Explore this database to discover Lyme disease incidence in your county.

Land use changes in Connecticut may have helped to enable Lyme's leap into humans

Forest clearing and fragmentation, alongside suburban development, may have contributed to the emergence of Lyme disease in humans in the 1970s. Those changes brought mice, carriers of the disease, into greater contact with people. Climate change is also facilitating Lyme's spread as tick populations survive milder winters and move northward.

Blood tests for Lyme disease tend to come up as false negatives in the week after a bite

It can take several weeks for Lyme antibodies to develop, which is what blood tests would be detecting. That's why many clinicians will prescribe antibiotic treatment immediately after a bite if the individual develops the characteristic bullseye rash of Lyme or gets bitten in an area of the country known to have high rates of Lyme.

The US military, concerned about potential deployments worldwide, has long funded experimental hantavirus vaccines and therapies.

Collaborations between the military, biotech, and academic researchers led to an experimental antibody treatment for the Andes hantavirus strain—the one that more readily passes between humans. As of spring 2026, it had only been tested in animals. The US Army has also tested a potential hantavirus vaccine in people. It published early findings in 2023 that seemed promising, eliciting some immune system response. (Some users may encounter a paywall.)

Live virus vaccines predated polio—that's how we vaccinate against smallpox

Since 1796, smallpox vaccines have used a live poxvirus related to smallpox. Yellow fever vaccines have used a live weakened form of the virus responsible for yellow fever since 1937.

What are universal vaccines?

As viruses mutate and develop, vaccines have to adapt, leading to regular recommended injections like flu shots. Researchers are working to develop universal vaccines that aim to protect against multiple virus variants if not entire virus families. These vaccines work by creating broadly neutralizing antibodies (bnAbs) that target aspects of viruses that don't typically mutate and are integral to the virus' survival.

Malaria vaccines are not routine because they have limited effectiveness.

Before vaccines, there was 'variolation': what was it?

Before the technology behind vaccinations was discovered, some keen observers of medicine around the globe noticed how previous infections could impact future ones. Learn about the techniques early physicians used before they had vaccines.

A 1954 outbreak at a Boston boarding school allowed scientists to isolate the measles virus and formed the basis for the first measles vaccine.

Wastewater testing has detected genetic evidence of polio, triggering vaccine boosters

Sampling of wastewater in London in 2022 detected fragments of polio virus, suggesting a vaccine-derived version of polio may be circulating. No one became ill, but the finding did trigger calls for a renewed booster inoculation campaign.

Cholera vaccines can protect people from disease for months—or even years

There are three recommended cholera vaccines on the market. The number of required shots and the period of protection they provide vary, but each of them can be life-saving.

Jonas Salk developed the first successful polio vaccine—and tested it on himself

The American medical researcher developed the inactivated virus vaccine from 1952 to 1955 and proved that it could prevent disease. He tested the virus on himself and his family in 1954 and then carried out formal clinical trials on more than 1.3 million children.

Powassan virus, a rare tick-borne disease named after the Canadian town where it was discovered in 1958, is on the rise in the northeastern United States, and it kills roughly 10% to 15% of patients with symptomatic disease.

Environmental conditions, shifting immunity, and viral strain could help explain 2025 spike

The surge in HFMD in the summer and early fall of 2025 in the mid-Atlantic could be the result of a confluence of factors, including a more virulent strain of disease-causing virus, good environmental conditions for the virus to spread—hot, humd—and a potential immunity gap among kids due to milder HFMD outbreaks the previous year.

West Nile virus was detected in UK mosquitoes for the first time in 2023

Fragments of the virus were detected in mosquitoes that were being collected in Britain for the first time in 2023, but the UK government considers the overall risk to people to be low. As of spring 2026, there have never been detected locally-acquired cases of the disease.

Deer don't get infected with Lyme disease—but ticks do feed on them

Adult ticks feed on white-tailed deer and also lay eggs on the animals, but the deer don't get sick with Lyme disease. Research published in 2023 offered new insights into why deer don't get sick from Lyme disease: It appears that the quadruped may have specific not-yet-identified immune system proteins in their blood serum that kill the bacterium.

See the evolution of Ebola vaccine and treatment development.

Erythema migrans rash is common in Lyme—but it often doesn't look like a bull's-eye

The US Centers for Disease Control and Prevention states that this rash occurs in roughly 70% or more of Lyme disease patients, and typically occurs at the site of a tick bite. The rash may expand slowly over several days and feel warm to the touch, but it's rarely itchy or painful. As it grows, areas of it may clear—creating a target or "bull's-eye" appearance.

Chronic lyme isn't a medically recognized diagnosis in conventional medicine

It describes a constellation of symptoms attributed to a persistent Lyme infection—meaning the bacteria have remained present even after antibiotics. It often occurs among people who have never received a positive test for Lyme. Doctors do recognize "post-treatment Lyme disease syndrome," however, which can include muscle and joint pain, fatigue, and cognitive difficulties after treatment for confirmed Lyme.

Ticks must typically be attached to a person for more than 24 hours to transmit Lyme

Infected blacklegged ticks must typically be attached to a person for more than 24 hours—and often closer to 36—to transmit Lyme. That period is enough time for the bacteria that causes Lyme to migrate from the tick's gut into the person's bloodstream while it's latched on through its bite. (There are rare documented cases of transmission under 24 hours.) Rapid removal of the tick is key to disease prevention.

Using mosquitoes to vaccinate bats could curb the spread of deadly diseases.

A scientist successfully treated her own breast cancer by injecting the tumor with lab-grown viruses.

A look at the 2025 measles outbreak in West Texas and surrounding areas

A measles outbreak in the summer of 2025 ultimately led to more than 900 cases and the deaths of two young children. The highly contagious virus requires vaccination rates near 95% to achieve herd immunity—the Texas outbreak spread through areas of significant mistrust of vaccines, including the area’s Mennonite community.

Most polio cases today are vaccine-derived rather than naturally occuring

Weakened, live virus vaccines—which aren't offered in the US—carry a risk of virus being shed in the stool. Rarely, the shed virus mutates and leads to vaccine-derived polio infections. Most recent polio cases are genetically linked to those vaccines. As shown in this graphic, there are typically hundreds of vaccine-derived polio cases annually.

A planned clinical trial to treat a rare lysosomal storage disorder in utero has buoyed hopes of providing prenatal gene therapies, but it was still awaiting FDA approval to begin enrolling patients as of May 2026.

West Nile was reported in 47 states in 2025, with more than 1,400 people severely affected

Tracking numbers from the CDC indicate that the virus spread widely that year, with more than 2,000 reported human cases and many states seeing more than 25 sickened people. More than 1,400 people had neuroinvasive cases of the disease—meaning the virus had entered the nervous system, which can cause severe, potentially life-threatening illness.

Only one strain of wild poliovirus continues to infect humans

Three strains of polio used to regularly infect humans, but two of the strains were declared eradicated in 2015 and 2019, respectively. In 2019, world health leaders estimated complete polio eradication—if achieved—would save $14B by 2050.

mRNA vaccines teach the immune system how to respond to a threat, using a molecule called messenger RNA.

COVID-19 vaccine breakthroughs are driving efforts toward a universal flu shot

mRNA and other technologies used for COVID-19 vaccines are being applied to influenza research. Scientists hope these advances will lead to a universal flu vaccine that protects against multiple strains and reduces the need for yearly shots.

Certain vaccinations may be more effective when given around the middle of the day.

There are two recommended malaria vaccines by world health experts, but both have limited effectiveness.

The best time to get a flu vaccine may be late-September or early-October

The body needs a few weeks after the vaccine to build up a sufficient antibody response, which eventually wanes. Scheduling the vaccine accordingly can maximize its effectiveness when flu season ramps up.

Attenuated vaccines introduce a weakened version of the virus into the body

Some vaccines, like those for measles, rely on weakened versions of a virus. These weakened pathogens are introduced into the body, triggering an immune response and helping the immune system learn to protect itself against stronger versions of the virus. (This also explains why some vaccines make you feel under the weather.)

A major US-designed polio vaccine was first tested in the Soviet Union

Albert Sabin's live attenuated virus vaccine—requiring two drops in the mouth—didn't garner political support in the US, so it was tested in the Soviet Union in the late 1950s.